Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 21-30 of 104 for alzheimer's

Edit search filters
  1. The Cognitive Effects of Lorazepam in Healthy Older Individuals with TOMM40 Variable-length Polymorphisms

    Scottsdale/Phoenix, AZ

  2. Open-Label Study of TRx0237 in Subjects With Alzheimer's Disease or Behavioral Variant Frontotemporal Dementia (bvFTD)

    Jacksonville, FL, Rochester, MN

  3. A Study to Evaluate the Efficacy and Safety of ABBV-8E12 in Subjects With Early Alzheimer's Disease

    Jacksonville, FL

  4. A Study to Evaluate Compensatory Training to Support Everyday Function and Adherence to Brain Healthy Lifestyle Changes in Those at Risk for Alzheimer's Disease

    Scottsdale/Phoenix, AZ

  5. Efficacy and Safety Trial of MK-8931 in Participants With Prodromal Alzheimer's Disease (MK-8931-019)

  6. The Study of Nasal Insulin in the Fight Against Forgetfulness (SNIFF)

    Jacksonville, FL, Rochester, MN

  7. Clinical Trial of Solanezumab for Older Individuals Who May be at Risk for Memory Loss

    Jacksonville, FL, Rochester, MN

  8. A Study of the Safety and Effectiveness of Suvorexant (MK-4305) for the Treatment of Insomnia in People who have Alzheimer's Disease

    Rochester, MN

  9. Efficacy and Safety Trial of Verubecestat (MK-8931) in Participants With Prodromal Alzheimer's Disease (MK-8931-019)

  10. A Safety, Methodological and Exploratory Biomarkers Study to Slow Disease Progression

    Jacksonville, FL

.

Mayo Clinic Footer